News
Despite the challenges, many people with psoriatic arthritis lead full, active lives through effective treatment and self-management strategies. Staying informed about the condition helps patients ...
Hosted on MSN1mon
J&J’s psoriatic arthritis therapy trial meets endpointsUS-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its monoclonal antibody Tremfya (guselkumab) for active psoriatic arthritis (PsA).
When I was diagnosed with psoriatic arthritis, my daughters were 3 and 5—active, energetic, and always wanting to play make-believe. The first thought that crushed me was, “Will I still be ...
Researchers argued that more active screening of people at high risk of psoriatic arthritis needs to take place, using more streamlined diagnostic procedures. “We need more education around ...
New study shows a subset of psoriatic arthritis patients can achieve long-term remission without DMARDs. Learn who benefits ...
Psoriatic arthritis combines painful joint inflammation ... affected joints often appear red and feel warm to the touch. This active inflammation distinguishes it from wear-and-tear arthritis ...
Patients with uveitis had a higher risk for psoriatic arthritis and psoriasis, whereas those with psoriatic arthritis had a higher risk for uveitis.
Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd (BSE: 532520, today announced that the UK’s ...
Teva and Alvotech announced that the U.S. Food and Drug Administration (FDA) approved SELARSDI (ustekinumab-aekn) injection as ...
Biocon Biologics receives UK MHRA marketing approval for Yesintek, biosimilar of ustekinumab: Bengaluru Monday, May 26, 2025, 11:30 Hrs [IST] Biocon Biologics, a fully integrated ...
Metabolic syndrome was independently associated with elevated levels of pain catastrophizing among patients with psoriatic arthritis and may impact disease activity. Metabolic syndrome (MetS) is ...
Fresenius Kabi Canada announces that its ustekinumab biosimilar, developed by Formycon AG, is now commercially available in Canada. Otulfi™ is indicated for the treatment of several serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results